Stereotactic Pelvic Reirradiation for Locoregional Cancer Relapse.

[1]  Michael Lock,et al.  Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial , 2019, The Lancet.

[2]  J. Lee,et al.  Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Henry,et al.  Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): A systematic review. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  P. Bondiau,et al.  Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy , 2017, Radiation oncology.

[5]  Henry Knipe,et al.  Oligometastases , 2016, Radiopaedia.org.

[6]  R. Orecchia,et al.  Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer. , 2015, The British journal of radiology.

[7]  A. Mahadevan,et al.  Stereotactic body radiotherapy (SBRT) reirradiation for pelvic recurrence from colorectal cancer , 2015, Journal of surgical oncology.

[8]  M. Hoogeman,et al.  Re-Irradiation: Outcome, Cumulative Dose and Toxicity in Patients Retreated with Stereotactic Radiotherapy in the Abdominal or Pelvic Region , 2012, Technology in cancer research & treatment.

[9]  J. Bibault,et al.  Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results , 2011, Radiation oncology.

[10]  M. Schell,et al.  Stereotactic body radiation therapy: the report of AAPM Task Group 101. , 2010, Medical physics.

[11]  R. Orecchia,et al.  Image-Guided Robotic Radiosurgery as Salvage Therapy for Locally Recurrent Prostate Cancer after External Beam Irradiation: Retrospective Feasibility Study on Six Cases , 2010 .

[12]  A. Piermattei,et al.  Stereotactic radiotherapy in recurrent gynecological cancer: a case series. , 2009, Oncology reports.

[13]  T. Lacornerie,et al.  Extracranial Stereotactic Radiotherapy: Preliminary Results with the CyberKnife® , 2009, Oncology Research and Treatment.

[14]  Mi-Sook Kim,et al.  Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma. , 2008, Japanese journal of clinical oncology.

[15]  V. Ozmen,et al.  Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  T. Lacornerie,et al.  Radiothérapie stéréotaxique robotisée par CyberKnife®: aspects techniques et indications , 2007 .

[17]  C. N. Coleman,et al.  CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. , 2003, Seminars in radiation oncology.

[18]  S. Waggoner.  Cervical cancer , 2003, The Lancet.

[19]  H. Putter,et al.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. , 2001, The New England journal of medicine.

[20]  James D. Cox,et al.  Consensus statement: Guidelines for PSA following radiation therapy , 1997 .